NR3C2 (Mineralocorticoid Receptor) antagonists improve outcomes in patients with chronic heart failure caused by LV systolic dysfunction and hypertension by minimizing the cardiovascular damages88, 89. Here, NR3C2 is linked to hypertensive disorder.